Do you know that skin cancer is the most common form of cancer? And that it’s on the rise, with greater incidence over the past 30 years? In fact, the American Cancer Society estimates that, in 2013, almost 77,000 new melanomas will be diagnosed in the U.S. alone.

Learn how the Weizmann Institute is fighting melanoma and skin cancer.

Weizmann Honors Selas at Gala

Sara and Prof. Michael Sela were feted at the American Committee’s recent gala, hosted by the New York Region. Part of the Weizmann Institute family since 1950, Prof. Sela’s accomplishments include the drugs Copaxone® and Erbitux®. Click here to watch a video about the Selas and their beneficial impact on the Institute – and the world.